SIGN UP HERE!

With the right treatment, the time to face up to the bumps and blemishes of your rosacea is now. No matter where you are on your rosacea journey, going to a dermatologist can help get your treatment on track

Sign up to receive email and video resources, including skincare tips, lifestyle hacks, and advice on partnering with your dermatologist to help you manage the bumps and blemishes of your rosacea. Start receiving your rosacea insights today

Where are you in your rosacea journey?

Select the statement that most applies to you and subscribe now!

By providing your information, you consent to receiving marketing and promotional communications and other information from Galderma Laboratories, L.P. (“Galderma”). You hereby give consent to Galderma, its affiliates, and their agents and representatives to send communications and information to you via the contact information you have provided above. This consent will be in effect until such time as you opt-out of communications from Galderma. For more information, please review our privacy policy.

THE BUMPS AND BLEMISHES OF YOUR ROSACEA ARE UNIQUE TO YOU, AND YOUR TREATMENT SHOULD BE TOO!

Starting a conversation with your dermatologist and getting a tailor-made treatment plan that is right for you is the first step in helping to get the bumps and blemishes of your rosacea under control

By telling your dermatologist how you are feeling, they can better understand how rosacea is impacting you, both physically and emotionally. The time to face up to rosacea is now!

THANK YOU FOR YOUR RESPONSE!

We’ll be back in touch soon with more information to help you treat the bumps and blemishes of rosacea, and support you on your journey to clearer skin

WE’RE SORRY TO SEE YOU GO!

As you’ve chosen to opt-out, you will no longer receive updates from ORACEA® (doxycycline, USP) 40 mg* Capsules

If you would like to sign up again in the future, please visit oracea.com/hcp We hope to see you again soon!

IMPORTANT SAFETY INFORMATION

Indication: ORACEA® (doxycycline) 40 mg* capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. ORACEA does not lessen the facial redness caused by rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in subjects treated with ORACEA were nasopharyngitis, diarrhea, hypertension and sinusitis. Warnings/Precautions: ORACEA should not be used to treat or prevent infections. ORACEA should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years) and may cause reversible inhibition of bone growth. If Clostridium difficile associated diarrhea (CDAD) occurs, may need to discontinue ORACEA. Although photosensitivity was not observed in clinical trials, ORACEA patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA treatment beyond 16 weeks and safety beyond 9 months have not been established.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088

*30 mg immediate release and 10 mg delayed release beads

US-ORC-2100094